<DOC>
	<DOCNO>NCT01250847</DOCNO>
	<brief_summary>The primary objective study assess effect 'Seroquel-XR ' verbal learning ability people at-risk mental state ( ARMS ) 12 week period . The verbal learning ability index delay free recall score CVLT ( California Verbal learn Test ) , standard neuropsychological verbal memory test . The secondary objective ass effect 'Seroquel-XR ' cognitive function psychiatric symptom include psychotic , anhedonic symptom , impulsivity . The cognitive function ability measure standard neuropsychological test follow ; - Working memory : verbal &amp; spatial 2-back test - Attention : Digit Span , 3-7 CPT ( Continuous Performance Test ) - Executive function : WCST ( Wisconsin Card Sorting Test ) - Visuo-spatial ability : Rey Complex Figure Task copy - Visuomotor speed planning : Trail make test A &amp; B - Verbal fluency : Controlled Oral Word Association Test ( COWAT ) The scale psychiatric symptom use follow ; - Psychotic symptom : Scales Prodromal scale ( SOPS ) , Positive negative syndrome scale ( PANSS ) - Anhedonia : Social Anhedonia Scale ( SAS ) , Physical Anhedonia Scale ( PAS ) - Social cognition : Ambiguous Intention Hostility Questionnaire ( AIHQ ) - Impulsivity : Barrett Impulsivity Scale ( BIS )</brief_summary>
	<brief_title>Effects 'Seroquel-XR ' Improvement Neurocognitive Function People At-risk Mental States ( ARMS )</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>1 . Provision write informed consent 2 . Male female age 20 35 year 3 . Able understand comply requirement study ARMS : 4 . Female patient childbearing potential must use reliable method contraception negative urine human chorionic gonadotropin ( HCG ) test enrolment 5 . ARMS diagnose Structured Interview Prodromal Syndrome ( SIPS ) . Schizophrenia subject : 4 . Schizophrenia diagnose Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) . Patients schizophrenia ill 5 year . Subjects clinically stable stable antipsychotic therapy least 4 week prior baseline study . Normal control : 4 . Healthy volunteer history psychiatric illness first degree relative psychotic symptom include normal control . 1 . Pregnancy lactation 2 . Any DSMIV Axis I disorder define inclusion criterion . However , case ARMS , psychotic disorder NOS , major depressive disorder , obsessivecompulsive disorder , social phobia would allow . 3 . Patients , opinion investigator , pose imminent risk suicide danger self others 4 . Known intolerance lack response quetiapine fumarate , judge investigator 5 . Use follow cytochrome P450 3A4 inhibitor 14 day precede enrolment include limited : ketoconazole , itraconazole , fluconazole , erythromycin , clarithromycin , troleandomycin , indinavir , nelfinavir , ritonavir , fluvoxamine saquinavir 6 . Use follow cytochrome P450 3A4 inducer 14 day precede enrolment include limited : phenytoin , carbamazepine , barbiturate , rifampin , St. John 's Wort , glucocorticoids 7 . Administration depot antipsychotic injection within one dose interval ( depot ) randomisation 8 . Substance alcohol dependence enrolment ( except dependence full remission , except caffeine nicotine dependence ) , define DSMIV criterion 9 . Opiates , amphetamine , barbiturate , cocaine , cannabis , hallucinogen abuse DSMIV criterion within 4 week prior enrolment 10 . Medical condition would affect absorption , distribution , metabolism , excretion study treatment 11 . Unstable inadequately treat medical illness ( e.g . congestive heart failure , angina pectoris , hypertension ) judge investigator 12 . Involvement plan conduct study 13 . Previous enrolment randomisation treatment present study . 14 . Participation another drug trial within 4 week prior enrolment study long accordance local requirement 15 . A patient Diabetes Mellitus ( DM ) fulfil one follow criterion : Unstable DM define enrolment glycosylated hemoglobin ( HbA1c ) 8.5 percent . Admitted hospital treatment DM DM relate illness past 12 week . Not physician care DM Physician responsible patient 's DM care indicate patient 's DM control . Physician responsible patient 's DM care approve patient 's participation study Has dose oral hypoglycaemic drug ( ) ( ) diet 4 week prior randomisation . For thiazolidinediones ( glitazones ) period le 8 week . Taking insulin whose daily dose one occasion past 4 week 10 percent mean dose precede 4 week Note : If diabetic patient meet one criterion , patient exclude even treat physician believe patient stable participate study . 16 . An absolute neutrophil count ( ANC ) 1.5 fold 109 per liter</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>ARMS</keyword>
	<keyword>Ultra High Risk</keyword>
	<keyword>Quetiapine</keyword>
	<keyword>Verbal memory</keyword>
</DOC>